Coherus BioSciences, Inc.

The current price of CHRS is 2.00 USD — it hasn't changed in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Coherus BioSciences, Inc. stocks are traded under the ticker CHRS.

Coherus BioSciences, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

CHRS stock is 7.18% volatile and has beta coefficient of 2.67. Check out the list of the most volatile stocks — is Coherus BioSciences, Inc. there?

One year price forecast for Coherus BioSciences, Inc. has a max estimate of 15.00 USD and a min estimate of 4.00 USD.

CHRS earnings for the last quarter are −0.41 USD per share, whereas the estimation was −0.39 USD resulting in a −5.05% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about Coherus BioSciences, Inc. earnings.

Coherus BioSciences, Inc. revenue for the last quarter amounts to ‪74.57 M‬ USD despite the estimated figure of ‪81.78 M‬ USD. In the next quarter revenue is expected to reach ‪96.89 M‬ USD.

Yes, you can track Coherus BioSciences, Inc. financials in yearly and quarterly reports right on TradingView.

CHRS net income for the last quarter is ‪−79.65 M‬ USD, while the quarter before that showed ‪−39.64 M‬ USD of net income which accounts for −100.94% change. Track more Coherus BioSciences, Inc. financial stats to get the full picture.

Today Coherus BioSciences, Inc. has the market capitalization of ‪227.00 M‬, it has increased by 6.36% over the last week.

No, CHRS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, CHRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Coherus BioSciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.

CHRS reached its all-time high on Jul 22, 2015 with the price of 38.10 USD, and its all-time low was 1.43 USD and was reached on Nov 10, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 306.00 employees. See our rating of the largest employees — is Coherus BioSciences, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Coherus BioSciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Coherus BioSciences, Inc. stock shows the sell signal. See more of Coherus BioSciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Coherus BioSciences, Inc. future price: according to them, CHRS price has a max estimate of 15.00 USD and a min estimate of 4.00 USD. Read a more detailed Coherus BioSciences, Inc. forecast: see what analysts think of Coherus BioSciences, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Coherus BioSciences, Inc. EBITDA is ‪−193.23 M‬ USD, and current EBITDA margin is −73.63%. See more stats in Coherus BioSciences, Inc. financial statements.